These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2527829)

  • 1. Comparison of the effects of captopril and enoximone in patients with severe heart failure: a placebo controlled double-blind study.
    Cowley AJ; Stainer K; Wynne RD; Rowley JM; Hampton JR
    Int J Cardiol; 1989 Sep; 24(3):311-6. PubMed ID: 2527829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of enoximone in patients with heart failure uncontrolled by captopril and diuretics.
    Cowley AJ; Stainer K; Fullwood L; Muller AF; Hampton JR
    Int J Cardiol; 1990 Jul; 28 Suppl 1():S45-52; discussion 52-3. PubMed ID: 2145238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of hemodynamic effects of one-month oral captopril and enoximone treatment for severe congestive heart failure.
    Scriven AJ; Lipkin DP; Anand IS; Sutton GC; Poole-Wilson PA
    Am J Cardiol; 1987 Aug; 60(5):68C-71C. PubMed ID: 2956872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind, randomised, cross-over comparison of oral captopril and enoximone added to diuretic treatment in patients with severe heart failure.
    Scriven AJ; Lipkin DP; Anand IS; Sutton GC; Poole-Wilson PA
    J Cardiovasc Pharmacol; 1988 Jan; 11(1):45-50. PubMed ID: 2450255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral enoximone therapy in chronic heart failure: a placebo-controlled randomized trial. The Western Enoximone Study Group.
    Narahara KA
    Am Heart J; 1991 May; 121(5):1471-9. PubMed ID: 1826806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central and regional hemodynamic effects of oral enoximone in congestive heart failure: a double-blind, placebo-controlled study.
    Leier CV; Lima JJ; Meiler SE; Unverferth DV
    Am Heart J; 1988 May; 115(5):1051-9. PubMed ID: 2966546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind crossover comparison of enoximone and placebo in patients with congestive heart failure.
    Choraria SK; Taylor D; Pilcher J
    Circulation; 1987 Dec; 76(6):1307-11. PubMed ID: 2960473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of enoximone on quality of life.
    Baligadoo SJ; Subratty H; Manraz M; Tarral A; Maiti D; Murday M
    Int J Cardiol; 1990 Jul; 28 Suppl 1():S29-32. PubMed ID: 2145235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placebo-controlled trial of oral enoximone in end-stage congestive heart failure refractory to optimal treatment.
    Dubourg O; Delorme G; Hardy A; Beauchet A; Tarral A; Bourdarias JP
    Int J Cardiol; 1990 Jul; 28 Suppl 1():S33-42; discussion S43. PubMed ID: 2145237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disparity between improvement in left ventricular function and changes in clinical status and exercise capacity during chronic enoximone therapy.
    Leier CV; Binkley PF; Starling RC; Huss-Randolph P
    Am Heart J; 1989 May; 117(5):1092-8. PubMed ID: 2523634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of phosphodiesterase inhibitors to adrenergic agents in acutely ill patients.
    Vincent JL; Léon M; Berré J; Mélot C; Kahn RJ
    Int J Cardiol; 1990 Jul; 28 Suppl 1():S7-11. PubMed ID: 2145239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute effect of enoximone and captopril in patients with heart failure].
    Scholz M; Kneissl GD; Dieterich HA; Kaltenbach M; Bussmann WD
    Z Kardiol; 1991; 80 Suppl 4():69-74. PubMed ID: 1833901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind dose response comparison of oral enoximone and placebo for congestive heart failure.
    Zipperle G; Butzer F; Dieterich HA; Heinrich F
    Am J Cardiol; 1987 Aug; 60(5):72C-74C. PubMed ID: 2956873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of captopril on abnormalities of the peripheral circulation and respiratory function in patients with severe heart failure.
    Cowley AJ; Rowley JM; Stainer K; Hampton JR
    Lancet; 1984 Nov; 2(8412):1120-4. PubMed ID: 6150183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose enoximone improves exercise capacity in chronic heart failure. Enoximone Study Group.
    Lowes BD; Higginbotham M; Petrovich L; DeWood MA; Greenberg MA; Rahko PS; Dec GW; LeJemtel TH; Roden RL; Schleman MM; Robertson AD; Gorczynski RJ; Bristow MR
    J Am Coll Cardiol; 2000 Aug; 36(2):501-8. PubMed ID: 10933364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placebo-controlled study of oral enoximone in congestive heart failure with initial and final intravenous hemodynamic evaluation.
    Khalife K; Zannad F; Brunotte F; Belhadj K; Juilliere Y; Iannascoli F; Gilgenkrantz JM
    Am J Cardiol; 1987 Aug; 60(5):75C-79C. PubMed ID: 2956874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A preliminary report of the effects of orally administered enoximone on regional hemodynamics in congestive heart failure.
    Leier CV; Meiler SE; Matthews S; Unverferth DV
    Am J Cardiol; 1987 Aug; 60(5):27C-30C. PubMed ID: 2956864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Enoximone].
    Ventura G
    Medicina (Firenze); 1990; 10(2):191-3. PubMed ID: 2148796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of enoximone on exercise tolerance in patients with mild to moderate heart failure.
    Itoh H; Taniguchi K; Doi M; Koike A; Sakuma A
    Am J Cardiol; 1991 Aug; 68(4):360-4. PubMed ID: 1830450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemodynamic effects of new phosphodiesterase inhibitors in patients with coronary heart disease. A comparison between enoximone and R80122].
    Kazmaier S; Stephan H; Sonntag H
    Anaesthesist; 1995 Jun; 44(6):410-6. PubMed ID: 7653792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.